Congress May Study Cell Line Ownership

WASHINGTON—Congress may take up legislation to govern ownership of human tissue and cell lines. The issue of who owns a cell line—the human source of the original tissues and cells or the scientists who derived the cell line from them—has caught the fancy of two influential legislators. Sen. Albert Gore (D-Tenn.), vice chairman of the Congressional Biomedical Ethics Board, said that present confusion over the issue "could impede important research." He thinks legislation may be

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The issue of who owns a cell line—the human source of the original tissues and cells or the scientists who derived the cell line from them—has caught the fancy of two influential legislators. Sen. Albert Gore (D-Tenn.), vice chairman of the Congressional Biomedical Ethics Board, said that present confusion over the issue "could impede important research." He thinks legislation may be required, and would like to see it considered before Congress adjourns in 1988.

Rep. Robert Roe (D-N.J.), chairman of the House Science, Space and Technology Committee, seems less certain of the need for legislation, but has strongly urged extensive discussion.

The legislators made their remarks in tandem with the release late last month of a report, "Ownership of Human Tissues and Cells," from the Congressional Office of Technology Assessment.

Despite the report and Congressional interest, there appears to be no great demand among scientists for resolution of the ownership ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Tabitha Powledge

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours